FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Peritoneal topics
Peritoneal
Peritoneal Dialysis
Peritoneal Cavity
Dialysis System
Intraperitoneal
Abdominal Cavity
Hemodialysis
Anastomosis
Wireless Communication Device
Colorectal
Hydrogen Sulfide
Sulfonamide
Ultraviolet
Ultraviolet Light
Subcutaneous

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Peritoneal patents



      
           
This page is updated frequently with new Peritoneal-related patent applications. Subscribe to the Peritoneal RSS feed to automatically get the update: related Peritoneal RSS feeds. RSS updates for this page: Peritoneal RSS RSS


Automated dialysis system using piston and negative pressure

Date/App# patent app List of recent Peritoneal-related patents
07/10/14
20140194809
 Peritoneal dialysis systems and related devices and methods patent thumbnailPeritoneal dialysis systems and related devices and methods
A peritoneal dialysis system includes a base peritoneal dialysis system and a peritoneal dialysis fluid exchange system that operates independently of the base system. The base system includes a first cassette including a first patient line configured to be connected to a patient, and a pd cycler.
07/03/14
20140188040
 Automated dialysis system using piston and negative pressure patent thumbnailAutomated dialysis system using piston and negative pressure
A peritoneal dialysis system is provided that includes a hardware unit, a disposable unit received by the hardware unit, and a controller. The hardware unit includes a recessed area, a piston having a contact surface, a pneumatic source for supplying a negative pressure, and an actuator configured to move the contact surface of the piston into and out of at least a portion of the recessed area.
07/03/14
20140186375
 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases patent thumbnailCombination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
Pharmaceutical compositions comprising a nucleic acid, a gene delivery polymer, and at least one adjunctive chemotherapeutic drug for the treatment of mammalian cancer or hyperproliferative disorders and methods of using thereof for the treatment of mammalian cancer or hyperproliferative disorders by intratumoral, intraperitoneal or systemic injection.. .
06/12/14
20140162950
 Method for inhibiting peritoneal metastasis caused by gastric cancer cells patent thumbnailMethod for inhibiting peritoneal metastasis caused by gastric cancer cells
The present invention provides a method for inhibiting peritoneal metastasis caused by gastric cancer cells in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of a connective tissue growth factor (ctgf), wherein the ctgf binds to an integrin α3β1 of the gastric cancer cells. The present invention also provides a method for predicting peritoneal metastasis caused by gastric cancer cells in a subject comprising providing a peritoneal tissue from the subject; measuring a first expression amount of a connective tissue growth factor (ctgf) from the peritoneal tissue; and comparing the first expression amount to a reference expression amount of the ctgf from a non-peritoneal metastasis gastric cancer tissue..
05/29/14
20140148409
Fluid for peritoneal dialysis
The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and l-ascorbic acid 2-glucoside.. .
05/22/14
20140142106
 Method for treating peritoneal fibrosis patent thumbnailMethod for treating peritoneal fibrosis
The present invention provides a method for treating, preventing or reducing peritoneal fibrosis comprising administering to a subject in need thereof a pharmacologically effective dose of a type i cannabinoid receptor (cb1r) antagonist or a type ii cannabinoid receptor (cb2r) agonist. Also provided is a dialysis fluid for treating, preventing or reducing peritoneal fibrosis comprising electrolytes, an osmotic agent, a physiologically acceptable ph solution, and a pharmacologically effective dose of a cb1r antagonist or a cb2r agonist..
05/22/14
20140142051
 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue patent thumbnailCarbohydrate-based peritoneal dialysis fluid comprising glutamine residue
The present invention relates to a carbohydrate-based peritoneal dialysis fluid, containing a compound selected from the group consisting of glutamine, preferably l-glutamine; a dipeptide capable of releasing glutamine, l-glutamine in free form, preferably selected from the group consisting of glutaminyl-glycine, glycinyl-glutamine, glutaminyl-alanine, alanyl-glutamine; an oligopeptide consisting of two to seven glutamine, preferably l-glutamine residues; and mixtures thereof. The peritoneal dialysis fluids of the present invention are useful for inhibition of technical failure in a person undergoing peritoneal dialysis treatment..
05/22/14
20140141052
 Substrate having an electron donating surface with metal particles comprising palladium on said surface patent thumbnailSubstrate having an electron donating surface with metal particles comprising palladium on said surface
There is disclosed a substrate with an electron donating surface, characterized in having metal particles on said surface, said metal particles comprising palladium and at least one metal selected from the group consisting of gold, ruthenium, rhodium, osmium, iridium, and platinum, wherein the amount of said metal particles is from about 0.001 to about 8 μg/cm2. Examples of coated objects include contact lenses, pacemakers, pacemaker electrodes, stents, dental implants, rupture nets, rupture mesh, blood centrifuge equipment, surgical instruments, gloves, blood bags, artificial heart valves, central venous catheters, peripheral venous catheters, vascular ports, haemodialysis equipment, peritoneal dialysis equipment, plasmapheresis devices, inhalation drug delivery devices, vascular grafts, arterial grafts, cardiac assist devices, wound dressings, intermittent catheters, ecg electrodes, peripheral stents, bone replacing implants, orthopaedic implants, orthopaedic devices, tissue replacing implants, intraocular lenses, sutures, needles, drug delivery devices, endotracheal tubes, shunts, drains, suction devices, hearing aid devices, urethral medical devices, and artificial blood vessels..
05/15/14
20140135878
 Method and apparatus for peritoneal hypothermia and/or resuscitation patent thumbnailMethod and apparatus for peritoneal hypothermia and/or resuscitation
Embodiments of the invention provide apparatus, systems and methods for introducing fluids into a body cavity for hypothermic, resuscitative, or other treatment. One embodiment provides an apparatus for introducing fluids into a peritoneal cavity comprising an access device for insertion into subcutaneous tissue, an infusion member and an advancement member.
05/15/14
20140135403
 Use of cyclohexanehexol derivatives in the treatment of ocular diseases patent thumbnailUse of cyclohexanehexol derivatives in the treatment of ocular diseases
The present invention relates to methods of treating ocular diseases in a subject by administering to the subject a therapeutically effective amount of one or more cyclohexanehexyl derivatives, or salts thereof, or a medicament comprising a cyclohexanehexol derivative and a pharmaceutically acceptable carrier. More specifically, the invention provides a medicament comprising at least one cyclohexanehexyl derivative of formula (iii) or (iv) useful in preventing or treating ocular diseases, by modulating the folding, oligomerization or aggregation of amyloid β in ocular cells.
05/01/14
20140121618
Ergonomic system for drainage and disposal of bodily fluids
There is provided an ergonomic container for draining fluid from the pleural space or peritoneal cavity of a patient. The container is desirably easy to open, easy to pour, easy to hold, easy to control and keep from falling on the floor, and that has graphics that communicate the use and disposal of the container in a relatively simple and easy to understand manner..
05/01/14
20140121613
Ergonomic system for drainage and disposal of bodily fluids
There is provided an ergonomic container for draining fluid from the pleural space or peritoneal cavity of a patient. The container is desirably easy to open, easy to pour, easy to hold, easy to control and keep from falling on the floor, and that has graphics that communicate the use and disposal of the container in a relatively simple and easy to understand manner..
05/01/14
20140120619
System and method for producing tissue-engineered material
A system for producing a tissue-engineered material includes a hollow member and a mechanical stimulating unit. The hollow member is adapted to be implanted in a peritoneal cavity, and is to be positioned in the peritoneal cavity in a manner that a part of the hollow member contacts an inner wall surface of the peritoneal cavity for enabling formation of a biological tissue that encapsulates the hollow member.
04/10/14
20140100289
Methods and compositions for treating mammalian nerve tissue injuries
To achieve, an in vivo repair of injured mammalian nerve tissue, an effective amount of a biomembrane fusion agent is administered to the injured nerve tissue. The application of the biomembrane fusion agent may be performed by directly contacting the agent with the nerve tissue at the site of the injury.
04/10/14
20140099617
Patient simulation system for medical services or diagnostic machines
A system, method, and apparatus for a patient simulator that interacts with a diagnostic or therapeutic medical device. The system includes a computing device coupled to a patient module.
04/10/14
20140098359
Method and apparatus for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration, and/or peritoneal dialysis
The present invention pertains to a method for monitoring a treatment of a patient, preferably for monitoring hemodialysis, hemodiafiltration and/or peritoneal dialysis, the method comprising the steps of irradiating a sample of a dialysis liquid used in the treatment with irradiation light of at least a first irradiation wavelength, detecting light emitted by the irradiated sample in at least a first detection wavelength, the detection wavelength being different from the first irradiation wavelength, and determining the presence and/or concentration of at least one analyte in the sample on the basis of the detected light.. .
03/27/14
20140088493
Automated peritoneal dialysis cycler and methods of use
Automated peritoneal dialysis (apd) cycler systems and methods are disclosed. The apd cycler can include a heater tray with load cells configured to measure the weight of fluid contained within a heater bag and/or a drain bag.
03/13/14
20140074018
Method of performing peritoneal dialysis using pneumatic valves
A method of performing peritoneal dialysis includes: (i) locating a supply of fresh dialysis fluid above a patient's peritoneal cavity; (ii) locating a drain or a drain container below the patient's peritoneal cavity; (iii) connecting a supply line to the supply of fresh dialysis fluid and the patient's peritoneal cavity; (iv) connecting a drain line to the patient's peritoneal cavity and the drain or drain container; (v) pneumatically opening a supply line valve during a fill cycle; (vi) gravity filling the patient's peritoneal cavity with the supply line valve open during the fill cycle; (vii) pneumatically opening a drain line valve during a drain cycle; and (viii) draining the patient's peritoneal cavity with the drain line valve open during the drain cycle.. .
03/13/14
20140072604
Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation thereof, and cancer therapeutic agent comprising the micelle preparation as active ingredient
A therapeutic agent as a micelle preparation, comprising a copolymer having a hydrophilic polymeric moiety and a polycarboxylic acid derivative moiety; and an anti-cancer agent bonding to or encapsulated in the copolymer, wherein the micelle preparation may exhibit sustained drug release capability, and enables an extension of a retention time period of the anti-cancer agent in an abdominal cavity, is provided. A superior life-prolonging effect was found in an intraperitoneal administration mouse model compared with a case in which only an encapsulated drug is administered, and thus the present invention was completed accordingly..
03/06/14
20140066841
Systems and methods for treating chronic liver failure based on peritoneal dialysis
An artificial liver system for treating liver failure includes a reservoir to provide albumin-containing dialysis fluid to the patient's peritoneum, an implantable device including a pump to pump the fluid from the peritoneum to the bladder via respective catheters, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve data reflective of the patient's health; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The monitoring and control software allows a treating physician to remotely adjust the volume, time, and frequency with which fluid is pumped from the peritoneal cavity to the bladder based on the data reflective of the patient's health..
02/27/14
20140058316
High flux basket catheter for efficient, continuous flow peritoneal dialysis
A catheter for use in continuous flow peritoneal dialysis comprising an inflow tube and outflow tube, both connected on one end to a dialysis machine. The inflow tube is divided into a plurality of inflow auxiliary tubes, and the outflow tube is divided into a plurality of outflow auxiliary tubes, with all auxiliary tubes encased in a single external tube.
02/27/14
20140058315
High flux basket catheter for efficient continuous flow peritoneal dialysis
A catheter for use in continuous flow peritoneal dialysis comprising an inflow tube and an outflow tube, wherein both are connected on one end to a dialysis machine. The inflow tube is divided into a plurality of smaller inflow auxiliary tubes, and the outflow tube is divided into a plurality of smaller outflow auxiliary tubes.
02/27/14
20140058206
Surgical access system and related methods
A surgical access system including a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. Some embodiments of the surgical access system may be particularly suited for establishing an operative corridor to a surgical target site in the spine.
02/27/14
20140057829
Citrullinated histone h3 (cit h3) in septic shock
Methods of diagnosing sepsis, severe sepsis, or septic shock and predicting prognosis in subjects with septic shock, based on levels of citrullinated histone h3 (cit h3) in the subject, e.g., in a sample comprising serum (e.g., whole blood, serum, or plasma), cerebrospinal fluid, urine, saliva, or peritoneal fluid from the subject.. .
02/20/14
20140050751
Mesothelin vaccines and model systems
Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic t cell response.
02/13/14
20140044769
Composite absorbable/biodegradable rings for controlled drug delivery
A fiber-reinforced composite ring for the controlled release of at least one bioactive agent includes a biocompatible matrix reinforced with absorbable/biodegradable fibers capable of providing the mechanical properties needed for inserting and maintaining the ring in a body cavity for a desired period of time. Such ring system as can be used for the intravaginal, intraperitoneal, and subcutaneous delivery of at least one bioactive agent, including those used as contraceptives, antimicrobial agents, and/or antiviral agents, as well as those for the treatment of cancer..
01/30/14
20140031631
Method and apparatus for inducing therapeutic hypothermia
Methods and apparatus for delivering therapeutic hypothermia to a patient are provided which may include any number of features. One feature is a hypothermia system comprising a fluid source, a heat exchanger assembly, a catheter in fluid communication with the fluid source, and a pump system configured to infuse hypothermic fluid into a patient cavity and extract hypothermic fluid from the patient cavity.
01/16/14
20140018727
Peritoneal dialysis systems, devices, and methods
An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals.
01/16/14
20140018618
Access systems and methods of intra-abdominal surgery
An access system includes a proximal handle, an overtube coupled to the handle, and an endoscope port extending through handle and overtube sized for receiving an endoscope therethrough. The overtube includes anatomic wall securing system that secures a distal portion of the overtube within a hole in the anatomic wall.
01/16/14
20140017316
Methods and compositions for treating recurrent cancer
The present invention provides methods of treating recurrent cancer (such as recurrent ovarian, peritoneal, or fallopian tube cancer) in an individual, comprising administering to the individual an effective amount of a composition (such as nab-paclitaxel or abraxane®) comprising nanoparticles comprising a taxane and a carrier protein.. .
01/09/14
20140012395
Method of mending a groinal defect
A method of mending a groinal defect such as an indirect inguinal hernia, a direct inguinal hernia, and/or a femoral hernia. A space between the external oblique aponeurosis and the internal oblique aponeurosis is dissected superiorly and laterally to create a site for receiving a lateral portion of a prosthetic repair patch.
01/09/14
20140012180
Peritoneal drain and infusion
A method to remove ascites from a mammalian body including: draining ascites from the peritoneal cavity to the bladder of the mammalian body, and evacuating the drained ascites out of the bladder. The method may be practiced with a valved fistula implanted into the bladder to form a passage between the peritoneal cavity and the bladder..
01/02/14
20140005175
Substituted aromatic sulfur compounds and methods of their use
Wherein d, n, ra, rb, and rc are as herein defined, along with pharmaceutical compositions and methods of using compounds of formula ii for treating or reducing the risk of peritoneal carcinomatosis in a patient.. .
01/02/14
20140004185
Pharmaceutical composition
A pharmaceutical composition for intraperitoneal delivery of an anti-neoplastic agent is provided for treating cancers associated with aberrant mucin expression, preferably ovarian cancer and pancreatic, prostate, metastatic breast, bladder and lung cancers. The composition comprises nanomicelles loaded with the anti-neoplastic agent, and antibodies such as anti-muc16, anti-muc1 or anti-muc4 are conjugated to these nanomicelles.
12/26/13
20130345621
Hybrid blood and peritoneal dialysis treatment systems and methods
A method for a hybrid blood and peritoneal dialysis (“pd”) machine comprising: (i) determining whether a previous treatment left a last fill of dialysate in a patient's peritoneum; (ii) if a next treatment is a pd treatment, and if the previous treatment did not leave the last fill of dialysate, causing a pd treatment in which a first cycle is a fill cycle to be initiated; (iii) if the next treatment is a pd treatment, and if the previous treatment did leave the last fill of dialysate, causing a pd treatment in which a first cycle is a last fill drain cycle to be initiated; and (iv) if the next treatment is a blood treatment and if the previous treatment did leave the last fill of dialysate, causing a blood treatment including a last fill drain cycle to be initiated.. .
12/26/13
20130345295
Targeted oncolytic adenovirus for treatment of human tumors, constrcution method and application thereof
An oncolytic adenovirus vector and its potential application in cancer treatment and vaccination. The inventive vector (named ad-td-hil12) is derived from the human adenovirus group c type 5, more particularly including deletion of three adenovirus genes e1a-cr2, e1b19k and e3gp-19k, and a fused cdna sequence of p35 and p40 subunit of human il12 placed under the control of the e3gp-19k promoter.
12/19/13
20130338574
Oral medicinal composition for patients undergoing peritoneal dialysis and method for using same
The present invention provides an oral medicinal composition for peritoneal dialysis patients to suppress an increase of carbonyl compounds and/or advanced glycation/lipoxidation end products (ages) in the peritoneal cavity and peritoneal tissue after intraperitoneal administration of a glucose-containing peritoneal dialysis fluid, the oral medicinal composition comprising a pharmaceutically acceptable salt of pyridoxamine as an active ingredient.. .
12/19/13
20130338102
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions are provided. A novel cause of aseptic peritonitis is provided—aseptic peritonitis associated with gram positive microbial contamination of a dialysis solution.


Popular terms: [SEARCH]

Peritoneal topics: Peritoneal, Peritoneal Dialysis, Peritoneal Cavity, Dialysis System, Intraperitoneal, Abdominal Cavity, Hemodialysis, Anastomosis, Wireless Communication Device, Colorectal, Hydrogen Sulfide, Sulfonamide, Ultraviolet, Ultraviolet Light, Subcutaneous

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Peritoneal for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Peritoneal with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.6846

3782

4 - 0 - 76